Suggestions
Mark Poznansky
Director - Vaccine and Immunotherapy Center at Harvard Medical School
Mark Poznansky is a prominent physician and researcher in the field of infectious diseases, currently serving as the Director of the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital (MGH) and a Professor of Medicine at Harvard Medical School. He holds both an M.D. and a Ph.D., having completed his medical degree at the University of Edinburgh and his doctoral studies at Cambridge University in 1989.12
Professional Background
-
Current Roles:
- Director, Vaccine and Immunotherapy Center, Massachusetts General Hospital
- Professor of Medicine, Harvard Medical School
- Attending Physician in Infectious Diseases, Massachusetts General Hospital
-
Research Focus: Dr. Poznansky's research primarily revolves around immunology, particularly the mechanisms of immune cell migration. He is known for discovering fugetaxis, which describes the active movement of immune cells away from a source of infection or inflammation. His work aims to translate these findings into novel vaccines and immunotherapies targeting various conditions, including cancer, infectious diseases, and autoimmune disorders like type 1 diabetes.12
Contributions and Achievements
- Dr. Poznansky has been instrumental in establishing VIC as a hub for innovative research that bridges scientific discovery and medical product development. The center's work has received funding from prestigious organizations such as the National Institutes of Health and the Department of Defense.2
- He has also contributed to the scientific community through numerous patents and has founded several biotech companies focused on therapeutic innovations.2
- His commitment to education is evident in his role as a mentor for students at various academic levels, fostering the next generation of scientists.2
Summary
Mark Poznansky is a key figure in advancing vaccine research and immunotherapy strategies, combining his clinical expertise with innovative scientific approaches to tackle pressing health challenges. His leadership at VIC continues to impact both academic research and practical applications in medicine.
